Get started
Author

Edyta Cichocka

Response to anti‐SARS‐CoV ‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
2022 · Joanna Zaleska, Paulina Kwasnik, et al. · International Journal of Cancer · 24
Secondary acute lymphoblastic leukaemia in a multiple myeloma patient
2012 · Jaroslaw Piszcz, Lukasz Bolkun, et al. · Współczesna Onkologia · 16
PDF
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
2021 · Bożena Katarzyna Budziszewska, Aleksander Salomon-Perzyński, et al. · Cancers · 13
PDF
Second versus first wave of COVID-19 in patients with MPN
2022 · Tiziano Barbui, Alessandra Iurlo, et al. · Leukemia · 10
PDF
Molnupiravir is effective in patients with haematological malignancies
2023 · Łukasz Bołkun, Bartosz Pula, et al. · International Journal of Cancer · 9
Determinants of early triage for hospitalization in myeloproliferative neoplasm ( MPN) patients with COVID ‐19
2022 · Tiziano Barbui, Alessandra Carobbio, et al. · American Journal of Hematology · 9
Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers
2020 · Jan Styczyński, Krzysztof Czyżewski, et al. · Acta Haematologica Polonica · 9
Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult leukemia group
2025 · Klaudia Zielonka, Błażej Izdebski, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
PDF
Prognostic relevance of HSP70 antigen and antibody measurement in patients with acute myeloid leukemia of intermediate and unfavorable cytogenetic risk
2014 · Jarosław Piszcz, Łukasz Bolkun, et al. · Polskie Archiwum Medycyny Wewnętrznej · 7
PDF
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
2023 · Marta Sobas, Wanda Knopinska-Posluszny, et al. · Annals of Hematology · 5
PDF
The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia
2022 · Monika Szelest, Marta Masternak, et al. · PLoS ONE · 3
PDF
Expression of TIM-3 and Gal-9 Immune Checkpoints in Chronic Lymphocytic Leukemia: The Potential Role of Interleukin-27
2025 · Ewelina Wędrowska, Tomasz Wandtke, et al. · Current Issues in Molecular Biology · 2
PDF
DAC and CLAM are equally effective as early second induction in newly diagnosed AML patients with persistent leukemia in early bone marrow evaluation – a retrospective analysis of Polish Adult Leukemia Group
2024 · Kamil Brzozowski, Agnieszka Pluta, et al. · Acta Haematologica Polonica · 2
PDF
The Association between Immune Checkpoint Proteins and Therapy Outcomes in Acute Myeloid Leukaemia Patients
2023 · Lukasz Bolkun, Marlena Tynecka, et al. · Cancers · 2
PDF
A compelling case for central pathology review of multiparameter flow cytometry measurable residual disease results in Acute Myeloid Leukemia (AML) clinical trials: Data from the PALG-AML1/2016 multicenter randomized study
2025 · Agnieszka Wierzbowska, Anna Czyz, et al. · Blood · 1
Prospective assessment of measurable residual disease kinetics in intensively treated patients with Acute Myeloid Leukemia (AML) - results of the PALG-AML1/2016 study
2025 · Agnieszka Wierzbowska, Agnieszka Pluta, et al. · Blood · 1
PDF
The Premature Reduction of Venetoclax in an Initial Cycle of Ven-AZA Regimen for Unfit AML Patients Leads to Shortened Overall Survival - a Retrospective Study of Polish Adult Leukemia Group (PALG)
2024 · Lukasz Bolkun, Bozena Katarzyna Budziszewska, et al. · Blood · 1
Stratification Using ECOG, ADL and HCT-CI Scales, but Not CGA Enables Identifying Elderly AML Patients Fit for Intensive Chemotherapy - a Multicenter Study from Polish Adult Leukemia Group
2023 · Bozena Katarzyna Budziszewska, Michał Łomiak, et al. · Blood · 1
PDF
Breakthrough infections in MPN-COVID vaccinated patients
2022 · Tiziano Barbui, Alessandra Carobbio, et al. · Blood Cancer Journal · 1
PDF
Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
2022 · Tiziano Barbui, Alessandra Carobbio, et al. · Blood · 1
PDF
A Polish Acute Leukemia Group Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in Acute Myeloid Leukemia (AML) Patients ≤ 60 Years Old (PALG-AML1/2016)
2020 · Agnieszka Wierzbowska, Agnieszka Pluta, et al. · Blood · 1
POSTER: AML-585: The Prognostic Value of Day 14 Bone Marrow Blast Clearance Is Mutation-Dependent in Newly Diagnosed, Intensively Treated Acute Myeloid Leukemia
2026 · Zuzanna Nowicka-Kaszkowiak, Agnieszka Pluta, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-585: The Prognostic Value of Day 14 Bone Marrow Blast Clearance Is Mutation-Dependent in Newly Diagnosed, Intensively Treated Acute Myeloid Leukemia
2026 · Zuzanna Nowicka-Kaszkowiak, Agnieszka Pluta, et al. · Clinical Lymphoma Myeloma & Leukemia
Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy – a multicenter study from Polish Adult Leukemia Group
2026 · Bożena Katarzyna Budziszewska, Michał Łomiak, et al. · Annals of Hematology
PDF
Tyrosine kinase inhibitors, low intensity chemotherapy and allohct for adults with Philadelphia-positive acute lymphoblastic leukemia. Results of the polish adult leukemia group (PALG) ALL7 protocol
2025 · Sebastian Giebel, Elżbieta Patkowska, et al. · Blood
PDF
Works count: 39
Citation count: 125
H-index: 7
I10-index: 4
Year
Topic
Type